This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: UK's national security screening regime avoids overreach but prompts other concerns

By Victoria Ibitoye ( August 16, 2022, 15:19 GMT | Comment) -- Merging companies anxious about the UK’s new regime for screening deals for any threat to national security have so far seen it sidestep concerns of overreach since it came into force in January. But the regime is also far from perfect, displaying a lack of transparency in deal reviews, an often bewildering notification process, and potential for national security probes to step on the toes of merger control.Dealmakers anxious that the UK’s tough new national-security investment screening regime would be vulnerable to overreach are likely still reserving judgment, given that it only came into force in January....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login